Carafate
NDC 58914-171, Sucralfate, tablet, from Allergan, Inc..
- Product NDC
- 58914-171
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA018333
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58914-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/1
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58914-171-10 | 58914017110 | 100 TABLET in 1 BOTTLE (58914-171-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c87c6b50-6977-4fa7-ae98-40c0753f7aeeNADAC price for package 58914017110
GET /v1/drugs/nadac/58914017110
Use it
Look up 58914-171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58914-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58914-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.